Abbott HIV P24 Antigen Test Recall Limited To About 350 Kits
This article was originally published in The Gray Sheet
Executive Summary
A firm-initiated recall of Abbott's HIVAG-1 monoclonal HIV p24 antigen test kits initiated Feb. 13 stems from underfilled antibody vials and is limited to a single lot of about 350 test kits.
You may also be interested in...
Abbott Determined To Improve Image Of HIV Tests After Regulatory Setbacks
Applications submitted by African countries for Abbott's Determine rapid HIV diagnostic test will be evaluated by health care consulting firm Axios International at the end of April, Abbott said March 27.
Abbott Determined To Improve Image Of HIV Tests After Regulatory Setbacks
Applications submitted by African countries for Abbott's Determine rapid HIV diagnostic test will be evaluated by health care consulting firm Axios International at the end of April, Abbott said March 27.
Abbott Aims For Mid-Year Products Reintroduction Following Consent Decree
Abbott Laboratories hopes to reintroduce a number of its diagnostics products to the market in the second half of 2001 following a November 1999 consent decree issued by FDA.